Zacks Investment Research
10 Jun 2026, 22:45 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Top 1 mover · tap to explore
What the story claims
5 claims · each scored for market impact
Hims & Hers Health, Inc. is currently assigned a Zacks Rank of #5 (Strong Sell). — A 'Strong Sell' rating from a major research provider typically triggers selling pressure and negative sentiment.
-0.70The Zacks Consensus EPS estimate for Hims & Hers Health has decreased by 92.39% over the past month. — A massive downward revision in earnings expectations suggests deteriorating fundamentals or analyst pessimism.
-0.60Hims & Hers Health is expected to report an EPS of -$0.02 for the upcoming quarter, a 111.76% decline year-over-year. — Significant year-over-year profit deterioration is a negative signal for stock valuation.
-0.50Continue reading
6 related stories
Hims & Hers Health's consensus revenue estimate for the upcoming quarter is $689.29 million, a 26.52% increase year-over-year. — Strong revenue growth indicates expanding market share or demand, partially offsetting earnings declines.
Hims & Hers Health currently has a Forward P/E ratio of 724.5. — An extremely high P/E ratio suggests the stock is significantly overvalued relative to its earnings.
-0.20Which stocks this story touches
The company has a Zacks Rank of #5 (Strong Sell), a significant drop in EPS estimates, and a recent share price decline.
Go deeper
You just saw which tickers this one story hits. A free account turns that into a standing screen: the movers delivered on schedule, before the chart catches up.
On this page · free
In the platform
Free account, 30 seconds. No credit card. Covers all 10 tickers this story moves.
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Screener bridge
Catch the names this kind of story moves — before the chart does.
Get the full NIS Momentum results every Friday at 4PM ET — free via email or Telegram.
Zacks Investment Research
2h ago
